Endpoint Health

Endpoint Health

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

Endpoint Health is an early-stage, private biotech leveraging AI and diagnostics to advance precision medicine. Founded in 2020 and headquartered in Palo Alto's vibrant life sciences hub, the company is positioned in a high-growth sector but maintains a low public profile with minimal operational details available. Its stated focus on using AI to analyze data and optimize experiences suggests a platform-based approach to clinical decision support or diagnostic development, though its pipeline and business model remain undefined due to limited public information.

DiagnosticsAI / Machine Learning

Technology Platform

Inferred to be an AI/ML platform applied to diagnostic data for precision medicine, but not publicly detailed.

Funding History

2
Total raised:$60M
Series A$52M
Seed$8M

Opportunities

The company operates in the high-growth convergence of AI and precision diagnostics, a market with significant demand for tools that improve therapeutic decision-making and patient outcomes.
Its Palo Alto location provides access to top talent, capital, and potential partners in both tech and biopharma.

Risk Factors

Major risks include the failure of its AI platform to achieve clinical validation and regulatory approval, the high burn rate with no visible revenue, intense competition from established diagnostics firms and well-funded AI startups, and the operational risk associated with its complete lack of public disclosure.

Competitive Landscape

The competitive field is crowded with both large, established diagnostic companies (e.g., Roche, Abbott, Quest) investing heavily in AI, and numerous well-funded pure-play AI-healthcare startups (e.g., Tempus, Paige.AI, PathAI). Endpoint Health's differentiation, if any, is not currently apparent from public materials.